Case Study: Ofatumumab-Induced Remission in Refractory Panuveitis Accompanied by Multiple Sclerosis

• by Agni M. Konitsioti, Jeany Q. Lammert, Sabine Vay, Gereon R. Fink, Michael Schroeter, Clemens Warnke

• April 29, 2026

Vamikibart Shows Early Safety in Uveitic Macular Edema

Phase 1 nonrandomized trial reported no drug-related serious adverse events, but efficacy remains unproven

• by Kerri Miller

• May 7, 2026

• 3 min

Cell death in uveitis: pyroptosis, ferroptosis, apoptosis, and beyond

• by Jianxin Liu, Liming Mao, Guoqing Chen, Liang Zou, Yi Shi, Lingxi Jiang, Jiayu Meng

• May 5, 2026

The Art of Ophthalmology 2026

Showcasing artwork and images from across the spectrum of ophthalmology

• by Alun Evans

• May 4, 2026

• 13 min